| Entry |
|
|---|
| Name |
Iproniazid (INN) |
|---|
| Formula |
C9H13N3O
|
|---|
| Exact mass |
179.1059
|
|---|
| Mol weight |
179.219
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antibacterial (tuberculostatic), Antidepressant, Monoamine oxidase (MAO) inhibitor |
|---|
| Comment |
Hydrazide derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa00260 | Glycine, serine and threonine metabolism |
| hsa00330 | Arginine and proline metabolism |
| hsa00982 | Drug metabolism - cytochrome P450 |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07216 | Catecholamine transferase inhibitors |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06A ANTIDEPRESSANTS
N06AF Monoamine oxidase inhibitors, non-selective
N06AF05 Iproniazide
D02579 Iproniazid (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00950 Iproniazide
D02579 Iproniazid
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Amine oxidases
MAO
D02579 Iproniazid (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00950 Iproniazide
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 13
1 C8y C 20.3000 -16.1700
2 C5a C 21.5600 -16.8700
3 C8x C 19.1100 -16.8700
4 C8x C 20.3000 -14.7700
5 N1b N 22.7500 -16.1700
6 O5a O 21.5600 -18.2700
7 C8x C 17.9200 -16.1700
8 C8x C 19.1100 -14.0700
9 N1b N 23.9400 -16.8700
10 N5x N 17.9200 -14.7700
11 C1c C 25.2000 -16.1700
12 C1a C 26.3900 -16.8700
13 C1a C 25.2000 -14.7700
BOND 13
1 1 4 1
2 2 5 1
3 2 6 2
4 3 7 1
5 4 8 2
6 5 9 1
7 7 10 2
8 8 10 1
9 9 11 1
10 1 2 1
11 11 12 1
12 1 3 2
13 11 13 1
|
|---|
